BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/10/2015 3:04:00 PM | Browse: 895 | Download: 1297
Publication Name World Journal of Hepatology
Manuscript ID 21421
Country/Territory Italy
Received
2015-07-11 09:28
Peer-Review Started
2015-07-12 18:13
To Make the First Decision
2015-09-08 10:33
Return for Revision
2015-09-16 17:57
Revised
2015-09-30 18:51
Second Decision
2015-11-27 11:56
Accepted by Journal Editor-in-Chief
2015-11-28 00:54
Accepted by Company Editor-in-Chief
2015-12-02 14:41
Articles in Press
2015-12-02 14:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-12-07 09:48
Publish the Manuscript Online
2015-12-10 15:03
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C
Manuscript Source Invited Manuscript
All Author List Andrea Martini, Andrea Gallotta, Patrizia Pontisso and Giorgio Fassina
Funding Agency and Grant Number
Corresponding Author Dr. Giorgio Fassina, Xeptagen S.p.A., VEGA Science Park, Building Auriga, Via delle Industrie 9, 30175 Marghera, Venice, Italy. fassina@xeptagen.com
Key Words Hepatitis C virus; Treatment; Prognosis; Squamous cell carcinoma antigen-immunoglobulins M; Cirrhosis
Core Tip A high public health priority need is the development of biomarkers to screen for liver disease progression in hepatitis C virus (HCV)-positive patients. Serological squamous cell carcinoma antigen-immuno-globulins M has shown the ability to identify patients with progressive liver disease and patients at higher risk of hepatocellular carcinoma development. In this review we summarize the main clinical studies performed using this new circulating biomarker for monitoring cirrhosis progression in HCV-positive patients and to evaluate virological response to antiviral treatment.
Publish Date 2015-12-10 15:03
Citation Martini A, Gallotta A, Pontisso P, Fassina G. Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World J Hepatol 2015; 7(29): 2913-2919
URL http://www.wjgnet.com/1948-5182/full/v7/i29/2913.htm
DOI http://dx.doi.org/10.4254/wjh.v7.i29.2913
Full Article (PDF) WJH-7-2913.pdf
Full Article (Word) WJH-7-2913.doc
Manuscript File 21421-Review.doc
Answering Reviewers 21421-Answering reviewers.pdf
Audio Core Tip 21421-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 21421-Conflict-of-interest statement.pdf
Copyright License Agreement 21421-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 21421-Language certificate.pdf
Peer-review Report 21421-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 21421-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 21421-Scientific misconduct check.pdf
Scientific Editor Work List 21421-Scientific editor work list.pdf